| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5700893 | European Journal of Surgical Oncology (EJSO) | 2017 | 9 Pages |
Abstract
Despite aggressive treatment, less than half of the patients were dead of DSRCT within 2 years of presentation. Although a select group of patients who underwent CRS had improved OS, novel treatments are urgently needed.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
F.A. Angarita, S. Hassan, A.J. Cannell, B.C. Dickson, R.A. Gladdy, C.J. Swallow, A. Gupta, M.E. Blackstein, J.A. McCart,